Alvotech (ALVO) Change in Account Payables (2021 - 2026)

Alvotech (ALVO) posted Change in Account Payables of -$34.3 million for Q1 2026, down 146.88% on a QoQ basis from $73.2 million in Q4 2025, and down 1001.76% year-over-year from $3.8 million in Q1 2025.

Alvotech (ALVO) Change in Account Payables (2021 - 2026) Analysis & Trends

Alvotech's Change in Account Payables history runs 6 years deep, the most recent figure standing at -$34.3 million for Q1 2026.

  • Quarterly Change in Account Payables fell 1001.76% year-over-year to -$34.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.2 million (up 180.53% YoY) and the FY2025 annual result came in at $45.3 million, up 430.87% from the prior year.
  • Change in Account Payables was -$34.3 million for Q1 2026 at Alvotech, down from $73.2 million in the prior quarter.
  • Across five years, Change in Account Payables topped out at $73.2 million in Q4 2025 and bottomed at -$45.7 million in Q3 2025.
  • A 5-year average of $1.3 million and a median of $6.6 million in 2022 frame the typical range for Change in Account Payables.
  • Annual changes were most pronounced in 2025 — Change in Account Payables soared 634.86% — and 2026, when it slumped 1001.76%.
  • Alvotech's Change in Account Payables stood at $6.6 million in 2022, then surged by 393.11% to $32.3 million in 2023, then plunged by 142.35% to -$13.7 million in 2024, then surged by 634.86% to $73.2 million in 2025, then slumped by 146.88% to -$34.3 million in 2026.
  • Business Quant data shows ALVO's Change in Account Payables at -$34.3 million in Q1 2026, $73.2 million in Q4 2025, and -$45.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Haleon 89.42 Bn 87.55 Bn - -
2 Teva Pharmaceutical Industries 35.86 Bn 32.12 Bn 1.97 Bn -
3 Zoetis 32.46 Bn 30.52 Bn 1.62 Bn 62.00 Mn
4 Takeda Pharmaceutical 27.52 Bn 23.46 Bn 4.39 Bn 30.60 Mn
5 United Therapeutics 23.15 Bn 20.99 Bn 648.10 Mn -
6 RedHill Biopharma 21.17 Bn 21.17 Bn - -
7 Viatris 20.32 Bn 18.51 Bn 1.16 Bn 32.70 Mn
8 Neurocrine Biosciences 17.74 Bn 16.42 Bn 800.70 Mn -
9 Elanco Animal Health 12.63 Bn 12.20 Bn 785.00 Mn -
10 Alvotech 924.39 Mn 924.39 Mn 5.09 Mn -34.34 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -34.34 Mn
Mar 31, 2026 -34.34 Mn
Dec 31, 2025 73.25 Mn
Dec 31, 2025 73.25 Mn
Sep 30, 2025 -45.69 Mn
Sep 30, 2025 -45.69 Mn
Jun 30, 2025 13.95 Mn
Jun 30, 2025 13.95 Mn
Mar 31, 2025 3.81 Mn
Mar 31, 2025 3.81 Mn
Dec 31, 2024 -13.70 Mn
Dec 31, 2024 -13.70 Mn
Sep 30, 2024 -6.18 Mn
Sep 30, 2024 -6.18 Mn
Jun 30, 2024 7.17 Mn
Jun 30, 2024 7.17 Mn
Mar 31, 2024 -28.93 Mn
Mar 31, 2024 -28.93 Mn
Dec 31, 2023 32.34 Mn
Dec 31, 2023 32.34 Mn